FREMONT, CA-Boehringer Ingelheim, a German biotech company, will acquire a development and manufacturing facility of Amgen Inc. in Fremont, California. The board of directors from each company has approved the transaction, which is expected to be closed in March.
The Amgen Fremont facility measuring 100,000 square feet is a manufacturing facility with process development labs and pilot plant. Amgen received the facility when it acquired Abgenix in 2006. For the full story, go to San Fernando Valley Business Journal.
GlobeSt.com News Hub is your link to relevant real estate and business stories from other local, regional and national publications.
© Touchpoint Markets, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more inforrmation visit Asset & Logo Licensing.
